COVID-19 is having a significant impact on the blood community, and latest issue of AABB News contains several articles addressing the pandemic. The "High Priority" column summarizes actions by AABB and federal agencies in response to the coronavirus,
AABB recently launched a new website to share information with the public, blood collectors and clinicians about convalescent plasma from individuals who have recovered from COVID-19 (CCP). FDA recently announced new guidelines permitting the use of CCP as an investigational treatment for patients
Due to the ongoing COVID-19 pandemic, AABB has elected to delay the effective dates of the 32nd edition of Standards for Blood Banks and Transfusion Services (BBTS) and 11th edition of Standards for Immunohematology Reference Laboratories (IRL) to July 1, 2020.
The AABB Board of Directors approved Association Bulletin #20-02 this week, which recommends strategies for blood collection establishments to implement to protect the availability of blood nationally during the 2019 coronavirus disease (COVID-19) pandemic.
AABB's newest white paper explores how the blood community can help ensure collection efforts are sufficient to meet patients' needs without creating potential unneeded surpluses. AABB's Patient Blood Management (PBM) Subsection designed this resource to be a useful tool for both the blood community
